rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2004-1-27
|
pubmed:abstractText |
The present investigation retrospectively assessed the effect of an open-label switch to ziprasidone from other atypical antipsychotics on behavior, weight, and lipid levels in an adult population with autistic disorder.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0160-6689
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
110-3
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14744179-Adult,
pubmed-meshheading:14744179-Age Factors,
pubmed-meshheading:14744179-Antipsychotic Agents,
pubmed-meshheading:14744179-Autistic Disorder,
pubmed-meshheading:14744179-Cholesterol,
pubmed-meshheading:14744179-Female,
pubmed-meshheading:14744179-Humans,
pubmed-meshheading:14744179-Male,
pubmed-meshheading:14744179-Middle Aged,
pubmed-meshheading:14744179-Piperazines,
pubmed-meshheading:14744179-Retrospective Studies,
pubmed-meshheading:14744179-Thiazoles,
pubmed-meshheading:14744179-Treatment Outcome,
pubmed-meshheading:14744179-Weight Gain
|
pubmed:year |
2004
|
pubmed:articleTitle |
The effect of a switch to ziprasidone in an adult population with autistic disorder: chart review of naturalistic, open-label treatment.
|
pubmed:affiliation |
1315 1st Ave. N., Seattle, WA 98109, USA. sacohenmd@msn.com
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|